Alzheimer's drug shows promise in early results of study – Capital Gazette

Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study.

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Eli Lilly ,Graig Suvannavejh ,Japan Eisai Co ,Alzheimer Association ,Drug Administration ,Eisai Co ,Biogen Inc ,Mizuho Securities ,Massachusetts Based Biogen ,Indianapolis Based Eli Lilly ,